Angiotensin‐converting enzyme inhibitors vs ACEi plus angiotensin receptor blockers
Death (all causes) · people with diabetes and kidney disease
Angiotensin‐converting‐enzyme inhibitors (ACEi) alone showed no clear difference in all‐cause death Median compared with ACEi plus angiotensin receptor blockers (low certainty).
1 finding from 1 review
- Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic… 2024 · Cochrane Headline outcomes onlyRR 1.08 [0.49, 2.4]6 studies · 1166 participantsLow